SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-061221
Filing Date
2024-07-15
Accepted
2024-07-15 11:02:23
Documents
2
Period of Report
2024-07-15

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0209426-6k_scinai.htm 6-K 11807
2 PRESS RELEASE, DATED JULY 15, 2024 ea020942601ex99-1_scinai.htm EX-99.1 19229
  Complete submission text file 0001213900-24-061221.txt   32287
Mailing Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000
Business Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000 972-8-9302529
Scinai Immunotherapeutics Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37353 | Film No.: 241116169
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)